ITMO Santé Publique
ITMO Santé Publique
Date de modification : 01/12/2019 | Version : 1 | ID : 4363
| Général | |
| Identification | |
| Nom détaillé | Cohort of Adolescents Treated for Cannabis Abuse and Addiction |
| Sigle ou acronyme | INCANT |
| Thématiques générales | |
| Domaine médical |
Pediatrics Psychology and psychiatry |
| Pathologie, précisions | Addictions |
| Déterminants de santé |
Addictions Social and psychosocial factors |
| Mots-clés | protocol, family therapy, cannabis, treatment, abuse, adolescent, assessment |
| Responsable(s) scientifique(s) | |
| Nom du responsable | Falissard |
| Prénom | Bruno |
| Adresse | Inserm U669 Maison de Solenn 97 boulevard du Port Royal 75679 Paris Cedex |
| Téléphone | +33 (0)1 58 41 58 50 |
| falissard_b@wanadoo.fr | |
| Laboratoire | INSERM U669 |
| Organisme | National Institute of Health and Medical Research |
| Nom du responsable | Phan |
| Prénom | Olivier |
| Adresse | Inserm U669 Maison de Solenn 97 boulevard du Port Royal 75679 Paris Cedex |
| Téléphone | +33 (0)1 53 82 81 70 |
| olivier.phan@imm.fr | |
| Laboratoire | INSERM U669 |
| Organisme | National Institute of Health and Medical Research |
| Nom du responsable | Jouanne |
| Prénom | Celine |
| jouanne.celine@neuf.fr | |
| Organisme | Tolbiac Emergency Resource Centre |
| Collaborations | |
| Financements | |
| Financements |
Public |
| Précisions | Interministerial Mission to Combat Drugs and Drug Addiction (MILDT) |
| Gouvernance de la base de données | |
| Organisation(s) responsable(s) ou promoteur | INSERM - National Institute of Health and Medical Research |
| Statut de l’organisation |
Secteur Public |
| Organisation(s) responsable(s) ou promoteur | Mission Interministérielle de Lutte contre les Drogues et les Toxicomanies (MILDT) |
| Statut de l’organisation |
Secteur Public |
| Contact(s) supplémentaire(s) | |
| Caractéristiques | |
| Type de base de données | |
| Type de base de données |
Study databases |
| Base de données issues d'enquêtes, précisions |
Cohort study |
| Origine du recrutement des participants |
A selection of health institutions and services |
| Le recrutement dans la base de données s'effectue dans le cadre d'une étude interventionnelle |
Yes |
| Précisions |
Performed at group level (clusters) |
| Informations complémentaires concernant la constitution de l'échantillon | All patients between 13 and 18 years old requesting a “cannabis consultation” are seen by the research psychologist. After checking the inclusion criteria, the psychologist proposes the study to the patient and his/her family. If required, they may be given time to think about it and give their answer during a second consultation with the research psychologist. After reading the information sheet and signing their consent, the family is included in the randomised study and assigned to one of three therapies. The randomisation procedure is required by the European protocol.. The Urn Randomisation procedure is used (Stout 1994; Project Match). This is carried out by the research psychologist. |
| Objectif de la base de données | |
| Objectif principal |
To assess the interest in a specific therapy; Multidimensional Family Therapy (MDFT) is given to adolescents who are misusing or addicted to cannabis.
To develop a therapeutic method in the European context, especially in France, that is effective in the field of adolescent addiction; to develop psychotherapy evaluation methods. |
| Critères d'inclusion | Presenting with a diagnosis for cannabis abuse and addiction and to having at least one parent (or legal guardian) agreeing to participate in the treatment and study. It should be noted that the misuse of psychoactive substances, behavioural and/or psychiatric disorders often associated with cannabis do not constitute grounds for exclusion. |
| Type de population | |
| Age |
Adolescence (13 to 18 years) |
| Population concernée |
Sick population |
| Sexe |
Male Woman |
| Champ géographique |
International |
| Détail du champ géographique | Europe: France; Netherlands; Germany; Switzerland; Belgium. Adolescents and their parents in France were recruited from two specialised psychoactive substance addiction centres that offer consultations for young drug users according to the MILDT protocol: Tolbiac Emergency Resource Centre, part of the Institute Mutual Montsouris (Paris, thirteenth municipal district), and the Specialised Drug Addiction Treatment Centre (CSST) and Drug Addiction Support Centre (CEDAT) in Mantes-la-Jolie that are managed by the Mignot Hospital in Versailles. |
| Collecte | |
| Dates | |
| Année du premier recueil | 10/2006 |
| Année du dernier recueil | 12/2009 |
| Taille de la base de données | |
| Taille de la base de données (en nombre d'individus) |
< 500 individuals |
| Détail du nombre d'individus | 150 |
| Données | |
| Activité de la base |
Data collection completed |
| Type de données recueillies |
Clinical data Declarative data Paraclinical data |
| Données cliniques, précisions |
Medical registration |
| Données déclaratives, précisions |
Paper self-questionnaire |
| Détail des données déclaratives recueillies | Sociodemographic data; adolescent history; family composition; drug use; family history of psychiatric illness; legal record; treatment path; problems at school and relationship with peers. |
| Données paracliniques, précisions | Intake interview is available separately for adolescents and parents. This heteroquestionnaire, which takes about twenty minutes, allows the collection of sociodemographic data as well as information on adolescent history; family composition; drug use; family history of psychiatric illness; legal record; treatment path; problems at school and relationship with peers. There is a specific version for adolescents and one for parents. Additional form: demographic characteristics; age; nationality; family status; number of children (parents); details on work and education; current occupation; medical information; personal medical history; compilation of drug therapies. Personal Experience Inventory (PEI): The PEI is a self-administered questionnaire that assesses the severity drug use and related issues. Youth Self Report (YSR): abbreviated self-administered questionnaire that allows the adolescent to focus on behavioural and possible psychological disorders. The Child Behavioral Checklist (CBCL) is the parent version of the YSR. Adolescent Depression Rating Scale (ADRS): evaluates the presence and severity of depression in adolescents aged between 13 and 20 years old. Timeline Follow-Back method: TLFB is a structured interview that measures the progression of drug use in young people over time. ADI-Light: Adolescent Diagnostic Interview-Light is a structured interview that evaluates adolescent substance usage based on DSM-IV-TR criteria. |
| Existence d’une biothèque |
Yes |
| Contenu de la biothèque |
Fluids (saliva, urine, amniotic fluid, …) |
| Détail des éléments conservés | Urine: semi-quantitative analysis of cannabis in the urine is also carried out at baseline and at six and twelve months. |
| Paramètres de santé étudiés |
Health event/morbidity |
| Modalités | |
| Mode de recueil des données | Self-administered questionnaire (Intake Interview, PEI, YSR, CBCL, ADRS) and medical interview (Timeline Follow-Back method, ADI-Light). |
| Suivi des participants |
Yes |
| Détail du suivi | Weekly consultation. Initial assessment at 6 and 12 months. |
| Appariement avec des sources administratives |
No |
| Valorisation et accès | |
| Valorisation et accès | |
| Lien vers le document | http://www.mdft.org/mdft/media/files/Jouanne-et-al-%28comparaison-de-l-efficacite-de-la-MultiDimensional-Family-Therapy-%28MDFT%29-versus-la-Treatment-as-usual-Explicite.pdf |
| Accès | |
| Charte d'accès aux données (convention de mise à disposition, format de données et délais de mise à disposition) | Contact the scientist in charge. |
| Accès aux données agrégées |
Access on specific project only |
| Accès aux données individuelles |
Access on specific project only |
| A PROPOS | CATALOGUE | RESSOURCES | LIENS UTILES
|  Ce site respecte les principes de la charte HONcode. Vérifiez ici. |
8 rue de la Croix Jarry 75013 Paris Tél: 01 44 23 67 47 |
Partenaires - F.A.Q. - Contact - Plan du site - Mentions légales - Administration - PEF-HD - Mis à jour le 15 décembre 2020 - Version 4.10.05
